Harbor Capital Advisors Inc. Sells 5,510 Shares of MKS Inc. $MKSI

04 Apr 2026, 10:00 by Kim Johansen · The Markets Daily

Harbor Capital Advisors Inc. lessened its stake in shares of MKS Inc. (NASDAQ:MKSI – Free Report) by 23.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,221 shares of the scientific and technical instruments company’s stock after selling 5,510 shares during the period. Harbor Capital Advisors Inc.’s holdings in MKS were worth $2,912,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Norges Bank purchased a new position in MKS in the second quarter valued at about $85,391,000. Frontier Capital Management Co. LLC increased its stake in shares of MKS by 146.4% during the 2nd quarter. Frontier Capital Management Co. LLC now owns 912,380 shares of the scientific and technical instruments company’s stock worth $90,654,000 after purchasing an additional 542,094 shares during the last quarter. Millennium Management LLC raised its holdings in shares of MKS by 9,165.9% in the 3rd quarter. Millennium Management LLC now owns 446,248 shares of the scientific and technical instruments company’s stock worth $55,232,000 after purchasing an additional 441,432 shares during the period. Rafferty Asset Management LLC raised its holdings in shares of MKS by 63.4% in the 2nd quarter. Rafferty Asset Management LLC now owns 878,114 shares of the scientific and technical instruments company’s stock worth $87,249,000 after purchasing an additional 340,645 shares during the period. Finally, Nomura Holdings Inc. lifted its stake in MKS by 316.9% in the third quarter. Nomura Holdings Inc. now owns 426,509 shares of the scientific and technical instruments company’s stock valued at $52,789,000 after purchasing an additional 324,195 shares during the last quarter. Institutional investors own 99.79% of the company’s stock.

Insiders Place Their Bets

In other news, Director Gerald G. Colella sold 10,000 shares of the company’s stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $253.97, for a total value of $2,539,700.00. Following the transaction, the director owned 40,017 shares of the company’s stock, valued at approximately $10,163,117.49. This represents a 19.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jacqueline F. Moloney sold 340 shares of the stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $213.77, for a total value of $72,681.80. Following the completion of the sale, the director owned 10,393 shares in the company, valued at $2,221,711.61. This trade represents a 3.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 68,503 shares of company stock worth $17,288,099. Company insiders own 0.57% of the company’s stock.

Analyst Upgrades and Downgrades

MKSI has been the subject of a number of recent research reports. Citigroup decreased their target price on MKS from $295.00 to $290.00 and set a “buy” rating for the company in a research report on Friday, March 20th. Bank of America upped their price target on MKS from $215.00 to $255.00 and gave the company a “buy” rating in a research report on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft increased their price target on MKS from $265.00 to $305.00 and gave the stock a “buy” rating in a research note on Thursday, February 19th. Wall Street Zen cut MKS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 3rd. Finally, TD Cowen upped their price objective on shares of MKS from $200.00 to $230.00 and gave the company a “buy” rating in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, MKS has a consensus rating of “Moderate Buy” and a consensus target price of $273.08.

Get Our Latest Analysis on MKS

MKS Price Performance

Shares of NASDAQ MKSI opened at $234.66 on Friday. The company has a quick ratio of 1.71, a current ratio of 2.71 and a debt-to-equity ratio of 1.53. The company has a market cap of $15.80 billion, a P/E ratio of 53.70, a P/E/G ratio of 1.26 and a beta of 1.90. MKS Inc. has a 52 week low of $54.84 and a 52 week high of $269.91. The business has a 50-day simple moving average of $236.67 and a two-hundred day simple moving average of $182.65.

MKS (NASDAQ:MKSI – Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.47 earnings per share for the quarter, missing the consensus estimate of $2.51 by ($0.04). MKS had a net margin of 7.53% and a return on equity of 20.85%. The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the company earned $2.15 earnings per share. The company’s quarterly revenue was up 10.5% on a year-over-year basis. MKS has set its Q1 2026 guidance at 1.720-2.280 EPS. Research analysts anticipate that MKS Inc. will post 6.94 earnings per share for the current fiscal year.

MKS Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 6th. Investors of record on Monday, February 23rd were issued a dividend of $0.25 per share. This is a boost from MKS’s previous quarterly dividend of $0.22. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. MKS’s payout ratio is currently 22.88%.

MKS Company Profile

(Free Report)

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.